RhumbLine Advisers
IBIO icon

RhumbLine Advisers’s iBio IBIO Stock Holding History

RhumbLine Advisers’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-455
Closed -$97K – 3158
2022
Q1 		$97K Sell
455
-55
-11% -$11.5K ﹤0.01% 2890
2021
Q4 		$140K Sell
510
-9
-2% -$3.43K ﹤0.01% 2899
2021
Q3 		$275K Buy
519
+15
+3% +$9.34K ﹤0.01% 2800
2021
Q2 		$381K Buy
504
+205
+69% +$150K ﹤0.01% 2680
2021
Q1 		$230K Buy
299
+85
+40% +$74.1K ﹤0.01% 2796
2020
Q4 		$112K Buy
214
+121
+130% +$98.6K ﹤0.01% 2956
2020
Q3 		$95K Buy
93
+4
+4% +$5.8K ﹤0.01% 2877
2020
Q2 		$99K Buy
+89
New +$58.2K ﹤0.01% 2971

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return